177 related articles for article (PubMed ID: 11811787)
1. Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival.
Gollapud S; Gupta S
J Clin Immunol; 2001 Nov; 21(6):420-30. PubMed ID: 11811787
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
3. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
5. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
Zhong L; Wu CH; Lee WH; Liu CP
J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
[TBL] [Abstract][Full Text] [Related]
6. CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism.
Daniel PT; Scholz C; Essmann F; Westermann J; Pezzutto A; Dörken B
Exp Hematol; 1999 Sep; 27(9):1402-8. PubMed ID: 10480431
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.
Johnstone RW; Cretney E; Smyth MJ
Blood; 1999 Feb; 93(3):1075-85. PubMed ID: 9920858
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.
Wu QL; Wu XP; Liang YJ; Chen LM; Ding Y; Fu LW
World J Gastroenterol; 2005 Jun; 11(23):3544-8. PubMed ID: 15962371
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
[TBL] [Abstract][Full Text] [Related]
11. The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death.
Cullen K; Davey R; Davey M
Cytometry; 2001 Mar; 43(3):189-94. PubMed ID: 11170105
[TBL] [Abstract][Full Text] [Related]
12. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
14. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
15. Induction of the IL-10 gene via the fas receptor in monocytes--an anti-inflammatory mechanism in the absence of apoptosis.
Daigle I; Rückert B; Schnetzler G; Simon HU
Eur J Immunol; 2000 Oct; 30(10):2991-7. PubMed ID: 11069082
[TBL] [Abstract][Full Text] [Related]
16. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
17. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
Stohl W; Xu D; Starling GC; Casali P; Kiener PA
Cell Immunol; 2000 Jul; 203(1):1-11. PubMed ID: 10915556
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
[TBL] [Abstract][Full Text] [Related]
19. Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.
Dorothee G; Ameyar M; Bettaieb A; Vergnon I; Echchakir H; Bouziane M; Chouaib S; Mami-Chouaib F
Int J Cancer; 2001 Mar; 91(6):772-7. PubMed ID: 11275978
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.
Gollapudi S; Jaidka S; Gupta S
J Clin Immunol; 2003 Jan; 23(1):11-22. PubMed ID: 12645856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
